Skip to main content
Wolfson Institute of Preventive Medicine - Barts and The London

BEST3 trial saves patient's life

Taking part in a Cancer Prevention Trial led to an unexpected diagnosis for one Plymouth patient

Published:
news image

The Cytosponge, shown fully expanded and in pill form.

A patient from Plymouth who took part of one of the Wolfson Institute’s Cancer prevention trials, Fred Mead, says that the experience was the ‘luckiest day of his life’. The CRUK-funded BEST3 Trial led by the University of Cambridge and King’s College London in partnership with Queen Mary University of London has been offering patients who take acid reflux medication the opportunity to have the novel Cytosponge™ test in a nurse-led appointment at their surgery. Read more about Fred’s story here.